These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3249991)

  • 1. [Concomitant use of 2 immunomodulators].
    Nobenaga M
    Ryumachi; 1988 Dec; 28(6):455-7. PubMed ID: 3249991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of immunomodulators in animal experimental models of rheumatoid arthritis].
    Abe C; Hirose S
    Ryumachi; 1988 Dec; 28(6):450-2. PubMed ID: 3249990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulators in the therapy of rheumatoid arthritis. I. The use of thymalin].
    Melekhin VD; Siniachenko VV; Khavinson VKh; Morozov VG
    Revmatologiia (Mosk); 1985; (3):43-6. PubMed ID: 3903930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunocorrective therapy of patients with rheumatoid arthritis].
    Perederiĭ VG; Zemskov AM; Nikitin AV; Evstratova EF; Zaikin VV; Zazhireĭ VD
    Vrach Delo; 1990 Mar; (3):68-70. PubMed ID: 2368368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of immunomodulating therapy in rheumatoid arthritis].
    Bassam B; Balabanova RM
    Ter Arkh; 1990; 62(5):32-5. PubMed ID: 2204139
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined immunomodulating therapy in rheumatoid arthritis].
    Oliunin IuA; Balabanova RM
    Ter Arkh; 1996; 68(5):13-6. PubMed ID: 9082588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and pokeweed mitogen induced in vitro immunoglobulin and IgM rheumatoid factor production by peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis.
    Patel V; Panayi GS; Unger A
    J Rheumatol; 1983 Jun; 10(3):364-72. PubMed ID: 6887161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The active rosette-formation reaction in assessing the immunomodulating activity of basic preparations in patients with rheumatoid arthritis].
    Senchilo IV; Vasil'eva EV
    Ter Arkh; 1992; 64(6):77-80. PubMed ID: 1440346
    [No Abstract]   [Full Text] [Related]  

  • 9. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic models used for the study of rheumatoid arthritis.
    Jasin HE; Cooke TD; Hurd ER; Smiley JD; Ziff M
    Fed Proc; 1973 Feb; 32(2):147-52. PubMed ID: 4688655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of immunomodulating and laser therapy in rheumatoid arthritis patients].
    Iarema NZ; Nazar PS; Zoria LV
    Vrach Delo; 1987 Apr; (4):59-61. PubMed ID: 3617643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunodepressive agents in therapy of rheumatoid arthritis. II. Changes in the titers of immunoglobulins and rheumatoid factor].
    Carrozzo M; Loizzi P; Arbore S; Latorre F; Pipitone V
    Folia Allergol (Roma); 1971; 18(2):121-6. PubMed ID: 5111809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial results of the clinical use of the immunostimulant bestatin (3-amino-2-hydroxy-4-phenylbutyryl leucine) in patients with chronic polyarthritis].
    Meske S; Vogt P; Maly FE; Seitz M; Müller W
    Z Rheumatol; 1985; 44(5):231-6. PubMed ID: 4082790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Side effects of immunomodulators and countermeasures].
    Kashiwazaki S; Suzuki S; Okada J
    Ryumachi; 1988 Dec; 28(6):460-3. PubMed ID: 2977863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Subreum efficacy and tolerance in patients with early rheumatic arthritis].
    Stepanets OV; Chichasova NV; Nasonova MB; Nasonov EL
    Klin Med (Mosk); 2001; 79(11):58-62. PubMed ID: 11811114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 17. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 1998; 70(5):32-7. PubMed ID: 9644739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
    Bingham SJ; Buch MH; Kerr MA; Emery P; Valadäo Barcelos AT
    Arthritis Rheum; 2004 Dec; 50(12):4072-3. PubMed ID: 15593202
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on clinical remission of rheumatoid arthritis].
    Itoh I; Amano K; Koide J; Takeuchi T; Matsuyama T; Abe T
    Ryumachi; 1992 Feb; 32(1):47-51. PubMed ID: 1604416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid irradiation in intractable rheumatoid arthritis: effects on the production of immunoglobulins and rheumatoid factors.
    Hanly JG; Hassan J; Moriarty M; Whelan A; Feighery C; Bresnihan B
    Clin Exp Immunol; 1985 Dec; 62(3):647-56. PubMed ID: 4085151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.